Challenges With Severe Coronary Artery Calcification in Percutaneous Coronary Intervention: A Narrative Review of

Jay S Shavadia1, Minh N Vo2, Kevin R Bainey2

  • 1Division of Cardiology, University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada.

Insights

Severe calcified coronary lesions pose a challenge during percutaneous coronary intervention (PCI). Plaque modification devices like atherectomy and lithoplasty offer effective therapeutic alternatives for interventional cardiologists.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Atherosclerosis commonly leads to coronary calcification, complicating treatment.
  • Aging populations and lower thresholds for percutaneous coronary intervention (PCI) increase the prevalence of severe calcific coronary stenoses.
  • Conventional PCI techniques are often insufficient for recalcitrant calcified lesions.

Purpose of the Study:

  • To summarize the principles, techniques, and evidence for devices used in treating severe coronary calcific lesions.
  • To provide an overview of current therapeutic options for complex coronary artery disease.
  • To highlight the role of plaque modification in interventional cardiology.

Main Methods:

  • Review of current literature on coronary atherectomy and lithoplasty devices.
  • Summary of procedural techniques for rotational, orbital, laser atherectomy, and shockwave lithoplasty.
  • Analysis of contemporary evidence supporting these devices for severe calcific lesions.

Main Results:

  • Coronary atherectomy and shockwave lithoplasty are established therapeutic alternatives for severe calcific coronary lesions.
  • These devices facilitate plaque modification, improving the success of PCI.
  • Evidence supports the safety and efficacy of various atherectomy modalities and lithoplasty.

Conclusions:

  • Advanced plaque modification devices are crucial for managing complex calcified coronary lesions.
  • Interventional cardiologists have multiple effective options for treating challenging stenoses.
  • These technologies represent significant advancements in treating severe coronary calcification.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
455
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
270
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
689
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.3K